Status:
COMPLETED
Effects of Mindfulness Meditation on Hemodialysis Patients
Lead Sponsor:
University of Jordan
Conditions:
End-Stage Renal Disease
Hemodialysis Complication
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objective: This study aimed to examine the effects of mindfulness meditation on the quality of sleep, perceived stress, serum cortisol, and C-reactive protein in end-stage renal disease patients under...
Detailed Description
End-stage renal disease (ESRD), or kidney failure, happens when the kidneys almost completely stop working, usually below 10-15% of normal function. It has been documented as a significant factor in r...
Eligibility Criteria
Inclusion
- Patients with ESRD who underwent hemodialysis thrice weekly for a minimum of one year.
- Were at least 18 years old.
- Having a urea reduction rate greater than 65% or Kt/V greater than 1.2 in the past month.
- Possessing Arabic literacy skills.
- Agreed to participate.
Exclusion
- Patients with cognitive dysfunction or mental retardation.
- Suffering from rheumatoid arthritis.
- Using a hearing aid.
- Regularly consuming psychopharmacological drugs to reduce stress and improve sleep.
- Participating in other psychological therapies at the time, or had prior formal training in mindfulness methods or a current meditation practice.
Key Trial Info
Start Date :
September 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT06936293
Start Date
September 15 2024
End Date
February 15 2025
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dialysis center at Jahra Governmental Hospital
Al Jahra, Kuwait, Kuwait, 00020